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ABSTRACT 
Objectives Delirium is a common, serious, underdiagnosed condition in acute medical and 
surgical inpatients. It is associated with increased risk of mortality and morbidity. Data are 
largely limited to developed countries in geriatric cohorts. Here we describe prevalence, risk 
factors and outcomes of delirium amongst general medical patients admitted to two hospitals 
in Cape Town, South Africa.  
Design and Setting Prospective cohort study of patients admitted acutely to a general 
medical inpatient service, in a  secondary and tertiary-level public hospital serving the Metro 
West area of Cape Town, South Africa. 
Participants Patients ≥ 18 years old were recruited daily from all acute medical admissions. 
Patients were excluded if they were aphasic or had Glasgow Coma Scale < 12/15. In total, 
808 patients were included.  
Main outcome measures Delirium was diagnosed using the validated confusion assessment 
method (CAM) tool performed by trained neuropsychologists.  Demographic data was 
collected by a clinical team and short and long-term mortality data were obtained using 
linkage analysis of hospitalised patients to routinely collected provincial death certification 
records.  
Results: The median age of inpatients was 51 (36-65) years. Twenty nine percent were 
proven HIV-infected. The overall prevalence of delirium was 12.3%. Multivariate predictors 
of delirium included: the presence of an indwelling urinary catheter (OR 4.37, CI 2.36-8.03), 
admission with a central nervous system disease (OR 4.37, CI 2.39-7.98), pre-existing 
cognitive impairment (OR 2.72, CI 1.11-6.64) and admission with a terminal disease (OR 
3.11, CI 1.09-8.89). HIV infection was not associated with increased risk of delirium. 
Delirium was associated with an increased risk for in-hospital (delirium vs. no delirium: 29% 
vs 12%; p < 0.01) and 12-month mortality (30% vs 20%; p < 0.01), as well as increased 
length of hospital stay (7 days vs 5 days, p < 0 .01). 
Conclusion: In this cohort of medical in-patients (with a relative young age and high HIV 
prevalence,) one in eight (12.3%) are delirious.. Delirium was associated with adverse 
outcomes. Delirium risk factors in this young cohort are similar to those in geriatric cohorts 
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Delirium is disorder of cerebral dysfunction, frequently encountered in acutely ill patients, 
and especially among elderly patients. The Diagnostic and Statistical Manual of Mental 
Disorders, 5th Edition (DSM-V) considers the following constellation of features diagnostic 
of delirium: disturbance in attention and awareness; disturbance in cognition and higher 
functioning; a short onset and fluctuating course; a clear precipitant must be identified, 
whether an acute illness, drug intoxication or withdrawal; with no other neurocognitive 
disorder identified to account for presentation.[1,2] Many precipitating factors for delirium 
have been described, including, many neurological conditions, local and systemic sepsis, 
metabolic derangements, pain, and iatrogenic interventions (e.g. surgical procedures and 
catheterisation). Premorbid cognitive dysfunction is an important risk factors for delirium. [3-7] 
 
Delirium is common amongst medical in-patients, with rates of 11- 42% reported. [3,7-9] The 
higher prevalence is found amongst geriatric populations[10,11] and intensive care units.[12] 
There are very few studies of delirium in unselected patients, particularly from low- and 
middle-income countries undergoing epidemiologic transitions, where there may be a greater 
burden of infectious disease including HIV, and relatively younger age of onset of non-
communicable diseases (NCDs). A 2015 systematic review on delirium in Sub-Saharan 
Africa described the scarcity of literature, with reported cohorts being very small; there were 
also technical difficulties with regards to terminology, diagnostic criteria and reporting of 
these studies. In contrast to high-income countries, patients were younger and more likely to 
have infectious precipitants.[13]  
 
Delirium has been associated with adverse outcomes including longer hospital stays, higher 
rates of re-admission, and increased short and long-term mortality. Consequently, there are 
greater individual, social and monetary implications associated with delirium.[3,8,14-22] Early 
management of delirium has been associated with shorten delirium duration and hospital 
length of stay, as well as improved functional outcomes.[23,24] Recognition of risk-factors is 
an important aid in the prevention of incident delirium. Measures to improve delirium 
assessment and management may have benefits in terms of improving healthcare for in-
patients[25,26], and incident delirium is used as part of quality assurance in many hospitals. 
Nevertheless, delirium is often undiagnosed in busy clinical settings.[27]  
 
We therefore aimed to describe the prevalence, risk factors and short- and long-term 
outcomes for patients admitted with a delirium to the acute medical service of two public 
hospitals in Cape Town, South Africa. Such knowledge would provide much needed data 
from a low-middle income country with a high background prevalence of HIV and NCDs. 
 
METHODS 
Study design and setting 
This is a prospective cohort study of acute medical admissions from 11 November 2013 to 7 
March 2014, at two university affiliated hospitals serving the Metro West area of Cape Town, 
South Africa. Groote Schuur Hospital has approximately 120 acute medical beds and serves 
as a tertiary referral centre; the majority of acute admissions are however admitted from the 
emergency department as “walk-ins”, a minority are referred from other hospitals in the areas 
for more specialised care.  Victoria Hospital has 80 acute medical beds and is a district level 
hospital. Acutely admitted patients in both hospitals are largely admitted to undifferentiated 
general medical wards under a single specialist consultant-run team. 
 
Participants 
Ten participants were randomly selected (using a electronic randomising sequence) from 
each day’s acute general medical admissions (daily intake total between 15-25 patients per 
day). Patients younger than 18 years old, patients withholding consent, aphasic patients, and 
patients with GCS < 12/15 were excluded.    
 
Delirium assessment 
Within 24 hours of admission, a study physician reviewed the patient’s charts and obtained 
data pertaining to the patient’s primary diagnosis, clinical background, admission medication, 
level of education, and demographic characteristics. An independent study neuropsychologist 
then assessed the patient for delirium using the confusion assessment method (CAM) 
performed during a 20-30-minute interview consisting of formal cognitive testing and also 
assessed delirium in conjunction with the study physician according to Diagnostic and 
Statistical Manual Fourth Edition (DSM IV) criteria. For all testing tools the presence of 
language barriers was noted, or a ward-based translator was used, when possible, so that 
testing was performed in the patients’ first language.  
 
Demographic data, presenting complaint, primary admission diagnosis and potential 
associates of delirium available from routine patient assessment were recorded from the 
patient, relatives and referring physician. Data on pre-admission functional status (in the form 
of Barthel Index of Activities of Daily Living), chronic medications at the time of admission, 
co-morbidities and blood results were collected. Although not a formal assessment tool for 
frailty, we used the Barthel Index as a marker for frailty as it refers to independence, 
functionality, mobility and strength, many of which are utilised in frailty scores. For analysis 
purposes we dichotomised laboratory values to clinically valuable “normal” or abnormal” 
results. For serum creatinine a simple round number cut off of 100µmol/L was used, 
signifying renal impairment in most people. Co-morbidities were defined as any pre-existing 
medical or surgical condition, present prior to the current admission. Data on HIV status, pre-
existing cognitive impairment, depression, visual/hearing impairment, and drug/alcohol abuse 
were also recorded where available. Pre-existing cognitive impairment was defined as any 
patient history suggesting cognitive decline prior to admission. Depression was defined as 
any patient history suggesting depressive symptoms present prior to the current admission. 
For analysis and reporting purposes, diagnoses were categorised as either communicable and 
non-communicable and classified into major and common groups for ease of reporting using 
ICD10 code grouping. 
 
Outcomes 
Length of hospital stay, in-patient mortality and 12-month mortality data were obtained from 
patient folders, the hospital electronic patient management system and the Western Cape 
Provincial death registry which links a unique patient identification number with national 
death certificate records and system wide electronic records.  Patients in whom no death 
record were available were deemed “Alive”. 
 
Statistical methods 
All data were analysed using in Stata 14 (Statacorp, TX, US).  Categorical variables were 
summarized as frequencies and percentages and continuous variables as medians with inter-
quartile ranges (IQR) if non-parametric. Socio-demographic, clinical characteristics and 
outcomes were assessed for differences between those with delirium and those without. 
Associations between categorical variables were analysed using the chi-square test and 
Fisher’s exact, as appropriate.  Wilcoxon rank-sum or Kruskal-Wallis test was used to 
compare continuous variables between two and three groups respectively.  
 
Univariable and multivariable logistic regression analysis were performed to identify risk 
factors for delirium. Risk factors that were strongly associated with delirium in the 
univariable analysis (p <0.05) were retained in a multivariable logistic regression model.  
Kaplan Meier survival curves for delirious vs non-delirious patients were compared using the 
Log-Rank test. A p < 0.05 was regarded as statistically significant. 
 
RESULTS  
1027 participants from all admissions were screened for inclusion into the study of which  
138 were excluded for the following reasons: 43 had a depressed level of consciousness with 
GCS < 12/15, 35 were not admitted directly into a general medical ward or transferred to 
another discipline, 47 were aphasic, 2 were deaf and could not effectively be tested, and 8 
demised before testing. A further 84 patients were not included in the final analysis: 49 had 
missing data and 35 refused consent. 808 participants were included in the analysis. 
 
Patient demographics (Table 1) 
The median (IQR) age was 51 (36-65) years; only 17.7% of participants were older than 70 
years. The cohort had equal gender distribution, with 52% female. The most frequent 
admission diagnoses were non-communicable disease of the cardiovascular (n=170), central 
nervous (n=86) and respiratory systems (n=76), followed by pulmonary tuberculosis (n=60) 
and non-tuberculous respiratory infections (n=58). The majority of patients were on chronic 
medication pre-admission (n=581, 72%), and 29% were using more than six chronic 
medications 
 
Delirium prevalence using either the DSM-IV or CAM reference methods did not differ 
significantly; thus, the results are presented using the CAM reference method. The overall 
prevalence of delirium was 12.3%. Patients with delirium were older (median age 55 vs 51 
years), were more likely to be “frail” (19% had pre-admission Barthel Score of < 50) and 
were more likely to have pre-existing predisposing factors for delirium such as cognitive 
impairment (14%), a terminal illness (9%) or a urinary catheter at home (30%).  The 
prevalence of an infection as primary admission diagnosis was similar in the delirium and 
non-delirium cohorts. Patients with delirium were more likely to have been admitted 
primarily because of a neurologic disease (Table 1).  
 
Twenty-nine percent of our cohort were confirmed HIV-infected with a median CD4 count of 
150 (IQR 66-132) cells/mm3. The median age of HIV-infected patients was lower than HIV-
uninfected patients [36 (IQR 30 – 44) vs. 52 (IQR 38 – 65) years, p < 0.01], there was a 
greater female predominance (n = 110, 60%) and a different profile of primary admission 
diagnoses, with a predominance of communicable diseases. In HIV-infected patients the 
prevalence of delirium was 13% and did not differ significantly from HIV-uninfected patients 
(Supplementary Table 1 reports on patients by HIV status). 
 
Predictors of delirium 
Table 2 shows univariable and multivariable logistic regression analysis of factors associated 
with delirium. After adjustment for co-variates, the multivariate predictors of delirium were 
presence of an indwelling urinary catheter (OR 4.37, CI 2.36-8.03), admission with a central 
nervous system disease (OR 4.37, CI 2.39-7.98), pre-existing cognitive impairment (OR 2.72, 
CI 1.11-6.64) and admission with a terminal disease (OR 3.11, CI 1.09-8.89). Neither HIV 
status, infection as the admission diagnosis, age, number of comorbidities, number chronic 
medications or any other laboratory abnormality were statistically significant in predicting 
delirium in this cohort.  
 
Outcomes 
Greater risk for adverse outcomes was seen with delirium (Table 3). The median length of 
hospital-stay was longer in patients with delirium (7 days vs. 5 days for patients without 
delirium, p < 0.01). In-patient mortality (29% vs 12%; p < 0.001) and 12-month mortality 
(30% vs 20%; p < 0.014) were greater in patients with delirium.  Figure 1 shows the Kaplan 
Meier survival curves for patients with and without delirium. Survival was significantly 
better without delirium (log-rank p=0.008), with the majority of difference associated with 




Delirium was common in this young cohort, diagnosed in 1 in every 8 patients admitted 
acutely to general medical wards in two public sector hospitals in Cape Town, South Africa. 
The predisposing factors for delirium were similar to those reported from geriatric cohorts, 
and included: premorbid cognitive impairment, presenceof a terminal illness, presence of an 
indwelling urinary catheter, age older than 70 years, immobility, and renal impairment 
(creatinine >100umol/l); the latter 3 variables not being retained in a multivaraiable model. 
We choose 70 years as a cut-off as it was collected in the original study as a risk factor for 
delirium. This age cut-off is frequently cited in literature on delirium. The only category of 
admission diagnosis associated with delirium was that of a disease of the central nervous 
system. Despite the high prevalence of HIV, HIV status was not associated with an increased 
risk of delirium, and neither were HIV-associated opportunistic infections. Admission 
delirium was associated with increased mortality, with differences predominantly associated 
with increased early mortality, although the difference was still evident up to 12-months post-
discharge.  
 
The overall rate of delirium in this study was 12.3%, falling within the range reported in 
international literature. [3,7-9] Importantly though, the composition of this cohort is distinct 
from the majority of published reports, and more generalisable to other low-middle income 
countries (LMIC). A 2006 systematic review by Siddiqi et al. looked at the occurrence and 
outcome of delirium in medical in-patients. In this review the mean age was older than 70 
years in 31 of the 33 cohorts in which age was reported, and HIV infection rates were not 
reported in any of the included cohorts.[8] In contrast, our median age was 50 years. Our study 
population is also unique by virtue of the higher incidence of HIV and HIV-related illnesses. 
[28,29] In spite of this, in our cohort HIV-status was not associated with increased risk for 
delirium. This is in contrast to a systemic review by Paddick et al. who consistently found 
HIV positivity to have a higher association with delirium.[30]  
 
The study has several strengths. It is the largest prospective study amongst acute general 
medical admissions in a low middle-income country. South Africa’s dual burdens of 
communicable and non-communicable diseases make it an important setting to consider 
delirium prevalence, risk factors and outcomes.[31] Reference testing was robust using well 
validated tools and performed by experienced neuropsychologists. Limitations included that 
national death certification records were not accessed – patients that moved province and 
died would thus have not been identified as such. We lacked a very detailed assessment of 
comorbidities, such as Charlson Index or comorbidity–polypharmacy score. This may have 
allowed a better understanding of the interplay between premorbid functioning, predisposing 
factors, precipitants and the development of delirium. We also did not capture data on 
readmission rates and functional status post-discharge. Such information might have further 
demonstrated that range of long-term sequelae in patients with delirium. Furthermore, 
different data are represented in different cohorts. This, together with the paucity of data for 
Sub-Saharan Africa makes it difficult to draw a direct correlation between our cohort and 
other cohorts. Unfortunately, this distracts from the generalisability of our results. 
 
In conclusion, our study informs acute general medical practice in LMICs. Delirium is 
common in this setting, an important predictor of morbidity and mortality. Like heart failure, 
respiratory failure and renal failure, “brain failure” should be awarded similar status. 
Delirium is underrecognized. There should be greater emphasis in the clinical training of 
doctors, nurses and carers, and members of allied health services to effectively screen for 
delirium and to ameliorate risk factors. As an important quality indicator, efforts should be 
made to ensure early detection and management. Research into why patients who develop 




Table 1: Characteristics for the overall cohort, stratified by presence/absence of delirium 
  
Overall 
n = 808 
No delirium  
n = 709 
With delirium 
n = 99 
p-value 
Age: median(IQR) 51 (36-65) 50.52 (35-65) 54.93 (40-70) 0.03 
Female: (%) 418 (52) 372 (52) 46 (46) 0.26 
Education: (n=765)  
Education in years, 
median(IQR) 9 (7-11) 9 (7-11) 9 (7-11) 
0.39 
< 7 years (%) 167 (22.00) 150 (22) 17 (23) 0.80 
Communication barriers 
present1(%)    
 
Deafness  12 (1) 8 (1) 4 (4)  0.05 
Dysphonia  6 (1) 6 (1) 0 (0)  0.46 
Language barrier  51 (6) 41(6)  10 (10)  0.10 
Visual impairment  18 (2) 12 (2)  6 (6)  0.02 
Dysarthria  36 (4)  27 (4)  9 (9)  0.02 
Risk factors for delirium: (%)  
Age > 70 years  143 (18) 118 (17) 25 (25) 0.04 
Presence of cognitive 
impairment 
39 (5) 26 (4) 13 (14)* < 0.01 
Terminal illness  23 (3) 14 (2) 9 (9)* < 0.01 
Depression 60 (7) 53 (7) 7 (7) 0.57 
Indwelling urinary catheter 79 (10) 50 (7) 29 (30)* < 0.01 
Immobility 108 (14) 83 (12) 25 (27)* < 0.01 
Number of comorbidities  2 (1-3) 2 (1-3) 3 (2-4)* < 0.01 
More than 3 comorbidities  355 (44) 300 (42) 55 (56) 0.01 
Barthel Index < 50  36 (5) 18 (3) 18 (19)* < 0.01 
Diagnostic category – 4 most 
frequent categories: (%) 
 
  
Communicable diseases:   
Pulmonary TB 60 (7) 53 (8) 7 (7) 0.54 
Respiratory infections 58 (7) 48 (7) 10 (10) 0,.6 
HIV-related infections 24 (3) 20 (3) 4 (4) 0.34 
GIT infections 23 (3) 20 (3) 3 (3) 0.55 
Non-communicable diseases:    
Cardiovascular disease 170 (21) 160 (23) 10 (10)* < 0.01 
CNS diseases 86 (11) 63 (9) 23 (23)* < 0.01 
Respiratory diseases 76 (9) 75 (11) 1 (1)* < 0.01 
Renal diseases 48 (6) 41 (6) 7 (7) 0.61 
HIV status:  
HIV positive (%) 183 (29) 159 (29) 24 (32) 0.51 
CD4 (cells/µL) median(IQR) 150 (66-312) 155 (66-313) 113 (60-282) 0.73 
Chronic medications: (%)  0.93 
None 227 (28) 198 (28) 29 (29)  
1-5 drugs 349 (43) 307 (43) 42 (42)  
> 6 drugs 232 (29) 204 (29) 28 (28)  
Admission investigations - 
median (IQR): 
 
Sodium (mmol/L) 139 (136-142) 139 (136-142) 140 (136-144) 0.08 
Potassium (mmol/L) 4.63 (4.16-5.20) 4.63 (4.20-5.18) 4.59 (4.03-5.21) 0.47 
Urea (mmol/L) 7.3 (4.9-9.3) 7.2 (4.8-9.1) 8.3 (6.0-15.5)* < 0.01 
Creatinine (µmol/L) 85.5 (68.0-99.0) 85.0 (67.0-98.0) 91.0 (74.0-195.0)* < 0.01 
Haemoglobin (g/dL) 11.90 (9.70-14.1) 11.90 (9.60-14.20) 11.20 (9.70-13.70) 0.33 
White cell count (cells/ µL) 9.13 (7.40-10.07) 9.18 (7.44-9.98) 9.03 (7.15-11.70) 0.99 
 
 
• Data are presented as n (%, rounded to nearest %) or median (IQR) 
* P < 0.01. P values for differences between those with and without delirium, calculated from Fisher’s exact, 




Table 2: Univariable and Multivariable analysis of predictors of delirium 
 
Variable Univariate OR  
(95% CI) 
p-value Multivariate OR  
(95% CI) 
p-value 
Male gender: 1.27 (0.83-1.94) 0.264   
Risk factors:    
Age > 70 years 1.69 (1.03-2.77) 0.037* 1.23 (0.66-2/31) 0.520 
HIV-infected 1.19 (0,71-2.00) 0.514   
Visual Impairment 2.3 (0.73 – 7.21) 0.18   
Depression 0.97 (0.42-2.2) 0.94   
Pre-existing Cognitive impairment 4.16 (2.06-8.41) <0.01* 2.72 (1.11-6.64) 0.029* 
Immobility 2.80 (1.67-2.68) <0.01* 1.86 (1.00-3.48) 0.051 
Terminal illness 5.07 (2.13-12.06) <0.01* 3.1 (1.09-8.89) 0.034* 
Indwelling catheter 4.54 (2.61-7.93) < 0.01* 4.37 (2.39-7.98) <0.001* 
Admission diagnosis – 4 most frequent 
categories: 
   
Communicable diseases:    
Pulmonary tuberculosis 0.94 (0.42-2.13) 0.886   
Respiratory infections 1.55 (0.76-3.17) 0.232   
HIV-related infections 1.45 (0.49-4.33) 0.505   
Gastrointestinal infections 1.08 (0.31-3.69) 0.907   
Non-communicable diseases:    
Cardiovascular disease 0.39 (0.20-0.76) <0.01   
Central nervous system diseases 3.10 (1.82-5.29) <0.01* 4.36 (2.39-7.98) <0.001* 
Respiratory diseases 0.09 (0.12-0.63) 0.016   
Renal diseases 1.24 (0.54-2.84) 0.612   
Admission investigations:    
Sodium (ref: 136-144 mmol/L)     
Serum sodium < 135 mmol/L 1.05 (0.60-1.86) 0.863   
Serum sodium > 145 mmol/L 2.54 (1.29-5.00) <0.01* 1.68 (0.75-3.78) 0.209 
Potassium (ref: 3.6-5.2 mmol/L)     
Serum potassium < 3.5 mmol/L 0.86 (0.33-2.26) 0.765   
Serum potassium > 5.3 mmol/L 0.79 (0.44-1.43) 0.441   
Serum creatinine > 100 µmol/l 2.10 (1.33-3.32) <0.01* 1.67 (0.96-2.88) 0.067 
Serum urea > 7 mmol/L  1.45 (0.942.25) 0.095   
Haemoglobin < 12.5 g/dL 1.44 (0.93-2.23) 0.103   





White cell count > 12 000 cells/µL 1.28 (0.77-0.12) 0.336   
White cell count < 4 000 cells/µL 0.66 (0.08-5.17) 0.691   










Table 3: Outcomes of patients with and without delirium 
Variable Total No delirium n (%) With delirium (n) p-value* 
Length of stay – median (IQR): 5 (3-9) 5 (3-9) 7 (4-12) 0.001 
In-patient mortality (%): 41 (5) 29 (4) 12 (12) 0.001 
3-month mortality (%): 135 (17) 105 (15) 30 (30) <0.001 
12-month mortality (%): 169 (21) 139 (20) 30 (30) 0.014 
*  Wilcoxon rank-sum  test 












Supplementary Table 1: Patient characteristics by HIV status 
Characteristics: Total  
(n = 786)* 
HIV negative  
(n = 444) 
HIV not tested  
(n = 159) 
HIV positive  










Female n(%) 315 (50.24) 205 (46.17) 94 (59.12) 110 (60.11) 
< 7 years school n(%) 124 (20.84) 91 (21.51) 91 (25.33) 33 (19.19) 
Communication 
barriers: n(%)     
Deafness 4 (0.64) 3 (0.68) 8 (5.03) 1 (0.55) 
Dysphonia 5 (0.80) 4 (0.90) 1 (0.63) 1 (0.55) 
Language barrier 45 (7.18) 19 (4.28) 5 (3.14) 26 (14.21) 
Visual impairment 12 (1.91) 11 (2.48) 5 (3.14) 1 (0.55) 
Dysarthria 23 (3.67) 19 (4.28) 11 (6.92) 4 (2.19) 
Risk factors: n(%)     
Cognitive impairment 23 (3.69) 17 (3.85) 15 (9.49) 6 (3.30) 
Age > 70 years 71 (11.32) 66 (14.86) 67 (42.14) 5 (2.73) 
Terminal illness 22 (3.53) 13 (2.93) 0 (0.00) 9 (4.97) 
Depression 47 (7.54) 36 (8.16) 10 (6.29) 11 (6.04) 
Visual impairment 14 (2.24) 10 (2.26) 3 (1.89) 4 (2.20) 
Indwelling catheter 53 (8.48) 38 (8.58) 21 (13.21) 15 (8.24) 
Immobility 70 (11.27) 57 (12.90) 33 (21.29) 13 (7.26) 
3+ comorbidities 238 (37.96) 171 (38.51) 105 (66.04) 67 (36.61) 
Barthel index < 50 24 (3.86) 20 (4.52) 10 (6.45) 4 (2.22) 
NCD’s: n(%) 395 (63.00) 330 (74.32) 125 (78.62) 65 (35.52) 
Central nervous 
system 62 (9.89) 55 (12.39) 20 (12.58) 7 (3.83) 
Cardiovascular system 108 (17.22) 91 (20.50) 55 (34.59) 17 (9.29) 
Respiratory system 65 (10.37) 55 (12.39) 11 (6.92) 10 (5.46) 
Gastrointestinal 
system 12 (1.91) 11 (2.48) 2 (1.26) 1 (0.55) 
Psychiatric illness 4 (0.64) 4 (0.90) 0 (0.00) 0 (0.00) 
Fluid and electrolyte 
abnormalities 15 (2.39) 14 (3.15) 4 (2.52) 1 (0.55) 
Drug and alcohol 
related conditions 13 (2.07) 9 (2.03) 1 (0.63) 4 (2.19) 
Cancer 17 (2.71) 13 (2.93) 6 (3.77) 4 (2.19) 
Renal system 40 (6.38) 36 (8.11) 7 (4.40) 4 (2.19) 
CD’s: 213 (33.97) 100 (22.52) 24 (15.09) 113 (61.75) 
Central nervous 
system infections 17 (2.71) 5 (1.13) 1 (0.63) 12 (6.56) 
Extrapulmonary TB 15 (2.39) 4 (0.90) 0 (0.00) 11 (6.01) 
Pulmonary TB 58 (9.25) 33 (7.43) 2 (1.26) 25 (13.66) 
TB meningitis 9 (1.44) 0 (0.00) 0 (0.00) 9 (4.92) 
HIV-related illnesses 24 (3.83) 1 (0.23) 0 (0.00) 23 (12.57) 
Urogenital infections 6 (0.96) 6 (1.35) 3 (1.89) 0 (0.00) 
Gastrointestinal 
infections 18 (2.87) 12 (2.70) 5 (3.14) 6 (3.28) 
Respiratory infections 41 (6.54) 27 (6.08) 12 (7.55) 14 (7.65) 
Drugs: 
No drugs 201 (32.06) 140 (31.53) 0 (0.00) 61 (33.33) 
1-5 drugs 269 (42.90) 176 (39.64) 0 (0.00) 93 (50.82) 
> 6 drugs 157 (25.04) 128 (28.83) 64 (40.25) 29 (15.85) 
Admission bloods: 
Sodium (mmol/L) 139 (136-142) 139 (136-142) 140 (138-143) 137 (132-140) 
135-145 430 (72.51) 332 (78.30) 122 (83.56) 98 (57.99) 
<135 128 (21.59) 65 (15.33) 10 (6.85) 63 (37.28) 
>145 35 (5.90) 27 (6.37) 14 (9.59) 8 (4.73) 
Potassium (mmol/L) 4.63 (4.16-5.20) 4.63 (4.16-5.20) 4.75 (4.34-5.23) 4.48 (4.02-5.05) 
3,5-5,3 460 (76.54) 327 (76.22) 113 (75.33) 133 (77.33) 
<3,5 36 (5.99) 24 (5.59) 6 (4.00) 12 (6.98) 
>5,3 105 (17.47) 78 (18.18) 31 (20.67) 27 (15.70) 
Urea (mmol/L) 7.30 (4.90-9.30) 7.30 (4.90-9.30) 8.50 (6.60-9.80) 5.90 (4.10-8.30) 
<7 300 (50.34) 196 (46.23) 43 (29.25) 104 (60.47) 
>7 296 (49.66) 228 (53.77) 104 (70.75) 68 (39.53) 
Creatinine (µmol/L) 85.5 (68-99) 85.50 (68-99) 94.5 (76-149) 80 (60-94) 
>100 113 (18.62) 96 (22.22) 53 (35.33) 17 (9.71) 
Haemoglobin (g/dL) 
11.90 (9.70-
14.10) 11.9 (9.7-14.1) 12.7 (9.8-14.4) 9.90 (9.30-12.25) 
<12,5 348 (58.00) 213 (50.24) 69 (46.31) 135 (76.70) 
White cell count 
(x109/L) 9.13 (7.40-10.07) 9.13 (7.40-10.07) 9.63 (8.46-12.39) 8.03 (6.10-9.39) 
Normal  485 (80.17) 327 (76.40) 110 (73.83) 158 (89.27) 
Leukopenia 12 (1.98) 8 (1.87) 0 (0.00) 4 (2.26) 
Leukocytosis 108 (17.85) 93 (21.73) 39 (26.17) 15 (8.47) 
Diagnosis of delirium: 
CAM 99 (12.3) 50 (11.23) 18 (11.46) 24 (13.12) 
DSM-IV 108 (13.5) 55 (12.47) 19 (12.10) 27 (14.84) 
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